New naloxone spray tested for faster overdose help
NCT ID NCT05377255
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new device (AP003) that delivers naloxone as a nasal spray to reverse opioid overdoses. Twenty-four healthy adults received multiple doses to see how the drug moves through the body and to check for side effects. The goal was to compare the new spray with an existing one (Narcan) and ensure it is safe and effective.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID OVERDOSE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Syneos Health Clinical Research Services
Miami, Florida, 33136, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Peer-led prevention: can gancheros help stop HIV, hepatitis c, and overdose in NYC?
- ER opioid overdose study pulled before it began
- Can an app save lives from overdose? philly trial aims to find out
- Can a computer predict overdose outbreaks? rhode island trial tests new tool
- New nalmefene study could speed up opioid overdose rescue
- ER study sheds light on hidden xylazine in opioid overdoses